Wednesday, 14. February 2007
Topic: DRUGS - on February 14, 2007 at 12:41:00 PM CET
Biotech firm in cannabis breakthrough
GW chairman Dr Geoffrey Guy said: "This agreement represents a landmark event in the history of GW. Not only have we secured the development and marketing of our lead product, Sativex, in the world's largest market, we have also selected a strategic partner that will allow us to extend our cannabinoid pipeline."
... Comment
